244 related articles for article (PubMed ID: 15350128)
21. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate.
Boutin JA; Marcheteau E; Hennig P; Moulharat N; Berger S; Delagrange P; Bouchet JP; Ferry G
J Pineal Res; 2008 Nov; 45(4):524-31. PubMed ID: 18826489
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols.
Gledhill JR; Montgomery MG; Leslie AG; Walker JE
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13632-7. PubMed ID: 17698806
[TBL] [Abstract][Full Text] [Related]
23. Cellular knock-down of quinone reductase 2: a laborious road to successful inhibition by RNA interference.
Chomarat P; Cogé F; Guénin SP; Mailliet F; Vella F; Mallet C; Giraudet S; Nagel N; Leonce S; Ferry G; Delagrange P; Boutin JA
Biochimie; 2007 Oct; 89(10):1264-75. PubMed ID: 17714848
[TBL] [Abstract][Full Text] [Related]
24. The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties.
Megarity CF; Gill JR; Caraher MC; Stratford IJ; Nolan KA; Timson DJ
FEBS Lett; 2014 May; 588(9):1666-72. PubMed ID: 24631540
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress and neurodegeneration: The possible contribution of quinone reductase 2.
Cassagnes LE; Chhour M; Pério P; Sudor J; Gayon R; Ferry G; Boutin JA; Nepveu F; Reybier K
Free Radic Biol Med; 2018 May; 120():56-61. PubMed ID: 29526807
[TBL] [Abstract][Full Text] [Related]
27. S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization.
Boutin JA; Bouillaud F; Janda E; Gacsalyi I; Guillaumet G; Hirsch EC; Kane DA; Nepveu F; Reybier K; Dupuis P; Bertrand M; Chhour M; Le Diguarher T; Antoine M; Brebner K; Da Costa H; Ducrot P; Giganti A; Goswami V; Guedouari H; Michel PP; Patel A; Paysant J; Stojko J; Viaud-Massuard MC; Ferry G
Mol Pharmacol; 2019 Mar; 95(3):269-285. PubMed ID: 30567956
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme.
Mailliet F; Ferry G; Vella F; Berger S; Cogé F; Chomarat P; Mallet C; Guénin SP; Guillaumet G; Viaud-Massuard MC; Yous S; Delagrange P; Boutin JA
Biochem Pharmacol; 2005 Dec; 71(1-2):74-88. PubMed ID: 16293234
[TBL] [Abstract][Full Text] [Related]
29. Expression of Quinone Reductase-2 in the Cortex Is a Muscarinic Acetylcholine Receptor-Dependent Memory Consolidation Constraint.
Rappaport AN; Jacob E; Sharma V; Inberg S; Elkobi A; Ounallah-Saad H; Pasmanik-Chor M; Edry E; Rosenblum K
J Neurosci; 2015 Nov; 35(47):15568-81. PubMed ID: 26609153
[TBL] [Abstract][Full Text] [Related]
30. In cellulo monitoring of quinone reductase activity and reactive oxygen species production during the redox cycling of 1,2 and 1,4 quinones.
Cassagnes LE; Perio P; Ferry G; Moulharat N; Antoine M; Gayon R; Boutin JA; Nepveu F; Reybier K
Free Radic Biol Med; 2015 Dec; 89():126-34. PubMed ID: 26386287
[TBL] [Abstract][Full Text] [Related]
31. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
Leung KK; Shilton BH
Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
[TBL] [Abstract][Full Text] [Related]
32. Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer's disease phenotype in mice.
Gould NL; Scherer GR; Carvalho S; Shurrush K; Kayyal H; Edry E; Elkobi A; David O; Foqara M; Thakar D; Pavesi T; Sharma V; Walker M; Maitland M; Dym O; Albeck S; Peleg Y; Germain N; Babaev I; Sharir H; Lalzar M; Shklyar B; Hazut N; Khamaisy M; Lévesque M; Lajoie G; Avoli M; Amitai G; Lefker B; Subramanyam C; Shilton B; Barr H; Rosenblum K
J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561584
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol as a kcat type inhibitor for tyrosinase: potentiated melanogenesis inhibitor.
Satooka H; Kubo I
Bioorg Med Chem; 2012 Jan; 20(2):1090-9. PubMed ID: 22189272
[TBL] [Abstract][Full Text] [Related]
34. Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis.
Boutin JA; Saunier C; Guenin SP; Berger S; Moulharat N; Gohier A; Delagrange P; Cogé F; Ferry G
Arch Biochem Biophys; 2008 Sep; 477(1):12-9. PubMed ID: 18502195
[TBL] [Abstract][Full Text] [Related]
35. Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein (RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography.
Hsieh TC; Wang Z; Deng H; Wu JM
Anticancer Res; 2008; 28(1A):29-36. PubMed ID: 18383821
[TBL] [Abstract][Full Text] [Related]
36. Loss of quinone reductase 2 function selectively facilitates learning behaviors.
Benoit CE; Bastianetto S; Brouillette J; Tse Y; Boutin JA; Delagrange P; Wong T; Sarret P; Quirion R
J Neurosci; 2010 Sep; 30(38):12690-700. PubMed ID: 20861374
[TBL] [Abstract][Full Text] [Related]
37. Structural basis of ConM binding with resveratrol, an anti-inflammatory and antioxidant polyphenol.
Rocha BA; Teixeira CS; Silva-Filho JC; Nóbrega RB; Alencar DB; Nascimento KS; Freire VN; Gottfried CJ; Nagano CS; Sampaio AH; Saker-Sampaio S; Cavada BS; Delatorre P
Int J Biol Macromol; 2015 Jan; 72():1136-42. PubMed ID: 25192853
[TBL] [Abstract][Full Text] [Related]
38. The stilbenes resveratrol, pterostilbene and piceid affect growth and stress resistance in mammalian cells via a mechanism requiring estrogen receptor beta and the induction of Mn-superoxide dismutase.
Robb EL; Stuart JA
Phytochemistry; 2014 Feb; 98():164-73. PubMed ID: 24361291
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities.
Maiti A; Reddy PV; Sturdy M; Marler L; Pegan SD; Mesecar AD; Pezzuto JM; Cushman M
J Med Chem; 2009 Apr; 52(7):1873-84. PubMed ID: 19265439
[TBL] [Abstract][Full Text] [Related]
40. Flavin adenine dinucleotide content of quinone reductase 2: analysis and optimization for structure-function studies.
Leung KK; Litchfield DW; Shilton BH
Anal Biochem; 2012 Jan; 420(1):84-9. PubMed ID: 21971443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
